| Deborah Barr, | |
|
4115 Buena Vista Ave, Baltimore, MD 21211-1513 | |
| (410) 908-3418 | |
| Not Available |
| Full Name | Deborah Barr |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 4115 Buena Vista Ave, Baltimore, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033627856 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 12683 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Deborah Barr, 4115 Buena Vista Ave, Baltimore, MD 21211-1513 Ph: (410) 908-3418 | Deborah Barr, 4115 Buena Vista Ave, Baltimore, MD 21211-1513 Ph: (410) 908-3418 |
News Archive
Patients at Virginia G. Piper Cancer Center Clinical Trials are the first in the nation to participate in a clinical trial to determine the safety, tolerability and preliminary activity of an investigational drug that targets cell-signaling proteins associated with the most common form of lung cancer, as well as other forms of cancer such as lymphomas and neuroblastoma.
Today, the Biden-Harris Administration announced a $2.1 billion investment to improve infection prevention and control activities across the U.S. public health and healthcare sectors.
Torchmark Corporation announced that its Board of Directors has raised the quarterly dividend to $.15 per share on all of the outstanding common stock of the Company held of record as of the close of business of the Company's transfer agent on January 6, 2010. The dividend will be paid on February 1, 2010.
An article in the current edition of Chemical & Engineering News, ACS's weekly newsmagazine, describes the trials, tribulations, and triumphs of one of the hottest pursuits in modern biomedical science - the search for "biomarkers" that could greatly improve the diagnosis of disease and efforts to monitor the effectiveness of treatment.
Eddingpharm continued to aggressively build its product portfolio by inking another cancer agreement, this time with Immutep. In this latest agreement, Eddingpharm was granted exclusive rights to develop and market ImmuFact® IMP321 in mainland China, Hong Kong, Macau, and Taiwan.
› Verified 7 days ago
Ms. Angela Faith Noppenberger, LCSW-C Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 2000 Girard Ave, Baltimore, MD 21211 Phone: 410-929-1596 | |
Tara Rice, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5146 Park Heights Ave, Suite 1, Baltimore, MD 21215 Phone: 410-664-6264 | |
Jennifer Pope, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10 E North Ave Ste 5, Baltimore, MD 21202 Phone: 443-310-3042 Fax: 443-652-5904 | |
Kathryn Petrarca, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 416 E 30th St, Baltimore, MD 21218 Phone: 410-889-0727 Fax: 410-889-0729 | |
Michelle Antoinette Goines, LCSW-C Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1522 N Ellamont St, Baltimore, MD 21216 Phone: 410-419-9823 | |
Melissa Franco, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6802 Mcclean Blvd, Baltimore, MD 21234 Phone: 410-444-3800 | |
Karen Burd, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4803 Yellowwood Ave, Baltimore, MD 21209 Phone: 443-613-4152 |